Invesco Zacks Mid-Cap ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CZA and other ETFs, options, and stocks.

About CZA

CZA holds a proprietary-selected portfolio of 100 mid-cap US stocks. The fund seeks to outperform pure market-cap indexes. 

Index-Tracked
Russell 3000 TR USD
Index-TrackedRussell 3000 TR USD
Category
Mid-Cap Blend
CategoryMid-Cap Blend
Number of holdings
103
Number of holdings103
Inception Date
Apr 2, 2007
Inception DateApr 2, 2007

What's in this fund

Sectors

As of November 26, 2025
Industrials21.93%
Financial Services21.50%
Technology9.51%
Consumer Cyclical9.44%
Real Estate9.34%
Healthcare9.10%
Basic Materials8.23%
Utilities7.81%
Consumer Defensive1.77%
Communication Services1.37%

CZA Key Statistics

AUM
183.56M
AUM183.56M
Price-Earnings ratio
19.79
Price-Earnings ratio19.79
30-Day yield
1.44
30-Day yield1.44
Average volume
2.37K
Average volume2.37K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$113.72
52 Week high$113.72
52 Week low
$90.08
52 Week low$90.08
Expense ratio
0.69
Expense ratio0.69

Stock Snapshot

The current Invesco Zacks Mid-Cap ETF(CZA) stock price is $111.86, with a market capitalization of 184.57M. The stock trades at a price-to-earnings (P/E) ratio of 19.79 and offers a dividend yield of 1.9%.

On 2025-11-29, Invesco Zacks Mid-Cap ETF(CZA) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.37K.

The stock's 52-week range extends from a low of $90.08 to a high of $113.72.

The stock's 52-week range extends from a low of $90.08 to a high of $113.72.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.